nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.0131	0.0516	CbGeAlD
Flunitrazepam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.0119	0.0468	CbGeAlD
Flunitrazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00908	0.0358	CbGeAlD
Flunitrazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00877	0.0346	CbGeAlD
Flunitrazepam—TSPO—forebrain—attention deficit hyperactivity disorder	0.0084	0.0331	CbGeAlD
Flunitrazepam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.0077	0.163	CrCbGaD
Flunitrazepam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.00765	0.162	CrCbGaD
Flunitrazepam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.00733	0.0289	CbGeAlD
Flunitrazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00711	0.028	CbGeAlD
Flunitrazepam—TSPO—cardiovascular system—attention deficit hyperactivity disorder	0.00711	0.028	CbGeAlD
Flunitrazepam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.00705	0.0278	CbGeAlD
Flunitrazepam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.00689	0.0272	CbGeAlD
Flunitrazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00684	0.027	CbGeAlD
Flunitrazepam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.0068	0.144	CrCbGaD
Flunitrazepam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.0068	0.144	CrCbGaD
Flunitrazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00662	0.0261	CbGeAlD
Flunitrazepam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.0065	0.138	CrCbGaD
Flunitrazepam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.00645	0.0254	CbGeAlD
Flunitrazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00637	0.0251	CbGeAlD
Flunitrazepam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00631	0.134	CrCbGaD
Flunitrazepam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00621	0.0245	CbGeAlD
Flunitrazepam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.00607	0.0239	CbGeAlD
Flunitrazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00579	0.0228	CbGeAlD
Flunitrazepam—GABRA6—brain—attention deficit hyperactivity disorder	0.0056	0.0221	CbGeAlD
Flunitrazepam—TSPO—midbrain—attention deficit hyperactivity disorder	0.00555	0.0219	CbGeAlD
Flunitrazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.00543	0.0214	CbGeAlD
Flunitrazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.0054	0.115	CrCbGaD
Flunitrazepam—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00525	0.0207	CbGeAlD
Flunitrazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.00506	0.0199	CbGeAlD
Flunitrazepam—GABRA4—brain—attention deficit hyperactivity disorder	0.00493	0.0194	CbGeAlD
Flunitrazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00493	0.0194	CbGeAlD
Flunitrazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00476	0.0188	CbGeAlD
Flunitrazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00474	0.0187	CbGeAlD
Flunitrazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00464	0.0183	CbGeAlD
Flunitrazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00458	0.0181	CbGeAlD
Flunitrazepam—TSPO—nervous system—attention deficit hyperactivity disorder	0.00456	0.018	CbGeAlD
Flunitrazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00448	0.0177	CbGeAlD
Flunitrazepam—TSPO—central nervous system—attention deficit hyperactivity disorder	0.00439	0.0173	CbGeAlD
Flunitrazepam—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00437	0.0172	CbGeAlD
Flunitrazepam—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00433	0.0171	CbGeAlD
Flunitrazepam—TSPO—cerebellum—attention deficit hyperactivity disorder	0.00429	0.0169	CbGeAlD
Flunitrazepam—CYP2A6—brain—attention deficit hyperactivity disorder	0.00426	0.0168	CbGeAlD
Flunitrazepam—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.0041	0.0162	CbGeAlD
Flunitrazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.00377	0.0148	CbGeAlD
Flunitrazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.00364	0.0143	CbGeAlD
Flunitrazepam—TSPO—brain—attention deficit hyperactivity disorder	0.00349	0.0137	CbGeAlD
Flunitrazepam—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00281	0.0111	CbGeAlD
Flunitrazepam—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.0027	0.0107	CbGeAlD
Flunitrazepam—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00264	0.0104	CbGeAlD
Flunitrazepam—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00254	0.01	CbGeAlD
Flunitrazepam—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00248	0.00977	CbGeAlD
Flunitrazepam—CYP2B6—brain—attention deficit hyperactivity disorder	0.00215	0.00846	CbGeAlD
Flunitrazepam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00212	0.00836	CbGeAlD
Flunitrazepam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00204	0.00805	CbGeAlD
Flunitrazepam—CYP2E1—brain—attention deficit hyperactivity disorder	0.00201	0.00794	CbGeAlD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00187	0.00268	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00186	0.00266	CbGpPWpGaD
Flunitrazepam—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00179	0.00257	CbGpPWpGaD
Flunitrazepam—UGT1A1—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00178	0.00255	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00172	0.00246	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0017	0.00244	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0017	0.00243	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00167	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00166	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00164	0.00235	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00164	0.00234	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00163	0.00233	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00161	0.0023	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0016	0.00229	CbGpPWpGaD
Flunitrazepam—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00158	0.00226	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00157	0.00225	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00156	0.00223	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00155	0.00221	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00154	0.0022	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00153	0.00218	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00151	0.00216	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0015	0.00215	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0015	0.00215	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00149	0.00213	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00148	0.00212	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00147	0.0021	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00146	0.00209	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00146	0.00209	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00143	0.00205	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00143	0.00205	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00141	0.00201	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00141	0.00201	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.0014	0.002	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0014	0.002	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00138	0.00198	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00138	0.00197	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00137	0.00195	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00136	0.00195	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00136	0.00195	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00136	0.00195	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00136	0.00194	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00134	0.00192	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00133	0.00191	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00132	0.00189	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00131	0.00187	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00186	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00129	0.00184	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00128	0.00184	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00128	0.00183	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00128	0.00182	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00127	0.00182	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00127	0.00181	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00126	0.0018	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00125	0.0018	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00121	0.00174	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00121	0.00173	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.00173	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0012	0.00172	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00119	0.0017	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00119	0.0017	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00118	0.00169	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00118	0.00169	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00117	0.00168	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00117	0.00167	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.00167	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00116	0.00166	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00116	0.00166	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00115	0.00164	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00112	0.00161	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00112	0.0016	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00112	0.0016	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0011	0.00157	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00108	0.00154	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00108	0.00154	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00107	0.00153	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00106	0.00151	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00104	0.00149	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00104	0.00149	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00149	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00104	0.00148	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00103	0.00147	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00103	0.00147	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00102	0.00147	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00102	0.00146	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00102	0.00146	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00101	0.00144	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.001	0.00144	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.001	0.00143	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000995	0.00142	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000992	0.00142	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000989	0.00141	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000985	0.00141	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000927	0.00133	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00092	0.00132	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000917	0.00131	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00091	0.0013	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000898	0.00128	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000894	0.00128	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000892	0.00128	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000887	0.00127	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00088	0.00126	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000855	0.00122	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000846	0.00121	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00084	0.0012	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000836	0.0012	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000836	0.0012	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000805	0.00115	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000799	0.00114	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000788	0.00113	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000782	0.00112	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000774	0.00111	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000768	0.0011	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000762	0.00109	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00076	0.00109	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000755	0.00108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000715	0.00102	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000653	0.000935	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000649	0.000929	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000648	0.000927	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000645	0.000922	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000644	0.000921	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00064	0.000916	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000636	0.00091	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000631	0.000903	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000627	0.000897	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000618	0.000884	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000568	0.000812	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000561	0.000802	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000551	0.000789	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000525	0.000751	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000498	0.000713	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000491	0.000702	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000489	0.0007	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000487	0.000697	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000484	0.000692	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000481	0.000688	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000471	0.000673	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000471	0.000673	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000447	0.00064	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000444	0.000635	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000443	0.000633	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000441	0.000631	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000427	0.000611	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000426	0.00061	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000426	0.00061	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00042	0.0006	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00041	0.000586	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00039	0.000558	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000382	0.000547	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00038	0.000543	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000377	0.000539	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000363	0.000519	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000363	0.000519	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000357	0.00051	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000341	0.000488	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000332	0.000474	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000329	0.000471	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000325	0.000464	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000295	0.000422	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000295	0.000421	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000295	0.000421	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000293	0.000419	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000291	0.000416	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00029	0.000415	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00029	0.000415	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000276	0.000395	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000269	0.000385	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000265	0.00038	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00026	0.000372	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000258	0.00037	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000257	0.000367	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000236	0.000337	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000227	0.000325	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000227	0.000325	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000224	0.000321	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000223	0.00032	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00022	0.000314	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000218	0.000312	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000208	0.000297	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000201	0.000287	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000183	0.000262	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000183	0.000262	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000183	0.000262	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000182	0.00026	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00018	0.000258	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000179	0.000257	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000179	0.000257	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000179	0.000255	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000177	0.000254	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000177	0.000253	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.000247	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000168	0.00024	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000164	0.000235	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000156	0.000224	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000146	0.00021	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000143	0.000205	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000139	0.000199	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000138	0.000198	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000138	0.000198	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000138	0.000197	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000137	0.000195	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.000195	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000136	0.000195	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000127	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000126	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000126	0.000181	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000124	0.000178	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000121	0.000173	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000115	0.000165	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000111	0.000159	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000111	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000111	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00011	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000109	0.000156	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000108	0.000154	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000108	0.000154	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000108	0.000154	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000106	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000151	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000101	0.000144	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.87e-05	0.000141	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.61e-05	0.000137	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	9.42e-05	0.000135	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.63e-05	0.000123	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	8.39e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	8.33e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	8.33e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.33e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.21e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	8.19e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.08e-05	0.000116	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	7.66e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	7.65e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.62e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	7.6e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.37e-05	0.000105	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.66e-05	9.52e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	6.54e-05	9.35e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.49e-05	9.28e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.34e-05	9.06e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.29e-05	9e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	5.9e-05	8.44e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.05e-05	7.22e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.01e-05	7.17e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	4.76e-05	6.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.66e-05	6.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.6e-05	5.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.28e-05	4.69e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.8e-05	4.01e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.16e-05	3.09e-05	CbGpPWpGaD
